Magnesium sulphate: The time of reckoning

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 2, 1996, Pages 99-102

  Robson, S C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; MAGNESIUM SULFATE; PHENYTOIN;

CLINICAL TRIAL; DRUG EFFICACY; ECLAMPSIA; FEMALE; HUMAN; MORBIDITY; NOTE; PREECLAMPSIA; PRIORITY JOURNAL;

ANTICONVULSANTS; CLINICAL TRIALS; DIAZEPAM; ECLAMPSIA; FEMALE; HUMANS; MAGNESIUM SULFATE; PRE-ECLAMPSIA; PREGNANCY;

EID: 0030047683     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09656.x     Document Type: Article

References (30)

1. Dommisse J. Phenytoin prophylaxis in severe pre-eclampsia and eclampsia [letter]. Br J Obstet Gynaecol 1994; 101: 361.
2. Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455–1463.
3. Lazard EM. A preliminary report on the intravenous use of magnesium sulphate in puerperal eclampsia. Am J Obstet Gynecol 1925; 9: 178–188.
4. Pritchard JA. The use of the magnesium ion in the management of eclamptogenic toxemias. Swg Gynecol Obstet 1955; 100: 131–140.
5. Zuspan FP. Treatment of severe pre–eclampsia and eclampsia. Clin Obstet Gynecol 1966; 9: 954–972.
6. Sibai BM, Lipshitz J, Anderson GD, Dilts PV Jr. Reassessment of intravenous MgSO, therapy in preeclampsia-eclampsia. Obstet Gynecol 1981; 57: 199–201.
7. Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: A randomized controlled trial. Br J Obstet Gynaecol 1990; 97: 110–117.
8. Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990; 97: 104–109.
9. Bhalla AK, Dhall GI, Dhall K. A safer and more effective treatment regimen for eclampsia. Aust NZ J Obsiet Gynaecol 1994; 34: 144–148.
10. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994; 309: 1395–1400.
11. American College of Obstetricians and Gynaecologists. Management of pre-eclampsia. ACOG Tech Bull 1986; 91: 1–6.
12. Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990; 162: 1141–1145.
13. Grant A, Elbourne D, Valentin L, Alexander S. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet 1989; 1: 345–349.
14. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low–dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–629.
15. Hutton JD, James DK, Stirrat GM, Douglas KA, Redman CWG. Management of severe pre-eclampsia and eclampsia by UK consultants. Br J Obstet Gynaecol 1992; 99: 554–556.
16. Robson SC, Redfem N, Seviour J, Campbell M, Walkinshaw S, Rodeck C, de Swiet M. Phenytoin prophylaxis in severe pre–eclampsia and eclampsia. Br J Obstet Gynacol 1993; 100: 623–628.
17. Belfort MA, Moise KJ Jr. Effect of magnesium sulphate on maternal brain blood flow in preeclampsia: a randomised, placebo-controlled trial. Am J Obstet Gynecol 1992; 167:661–666.
18. Cotton DB, Hallak M, Janusz C, Irtenkauf SM, Berman RF. Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. Am J Obstet Gynecol 1993; 168: 974–978.
19. Sipes SL, Weiner CP, Gellhaus TM, Goodspeed JD. Effects of magnesium sulfate infusion upon plasma prostaglandins in pre-eclampsia and preterm labor. Hypertens Pregn 1994; 13: 293–302.
20. McGiff JC, Carroll MA. Eicosanoids in preeclampsia-eclampsia: the effects of magnesium. Hypertens Pregn 1994; 13: 217–226.
21. Dickens BF, Weglicki Y, Li S, Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 1992; 311: 187–191.
22. Nelson SH, Suresh MS. Magnesium sulphate-induced relaxation of uterine arteries from pregnant and nonpregnant patients. Am J Obstet Gynecol 1991; 164: 1344–1350.
23. Guzman ER, Conley M, Stewart R, Ivan J, Pitter M, Kappy K. Phenytoin and magnesium sulfate effects on fetal heart rate tracings assessed by computer analysis. Obstet Gynecol 1993; 82: 315–379.
24. Atkinson MW, Belfort MA, Saade GR, Moise KJ Jr. The relation between magnesium sulfate therapy and fetal heart rate variability. Obstet Gynecol 1994; 83: 967–970.
25. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants Pediatr 1995; 95: 263–269.
26. Lucas MJ, Leverno KJ, Cunningham FG. A comparison of magnesium sulphate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201–205.
27. Chua S, Redman CW. Are prophylactic anticonvulsants required in severe pre–eclampsia Lancet 1991; 337: 250–251.
28. Moodley J, Moodley VV. Prophylactic anticonvulsant therapy in hypertensive crises of pregnancy–the need for a large, randomized trial. Hypertens Pregn 1994; 13: 245–252.
29. Winkler AW, Smith PK, Hoff HE. Intravenous magnesium sulfate in the treatment of nephritic convulsions in adults. J Clin Invest 1942; 21: 207–210.
30. Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 1984; 150: 728–733.